The Technology team advised Apollo Intelligence in its sale to Frazier Healthcare Partners.
Apollo will continue to focus on elevating industry standards for research and data-driven insights. The new relationship with Frazier—extending Apollo’s value to healthcare and life science clients — will fuel innovation and scale.
Apollo is a global insights innovator in the healthcare, life sciences, and tech industries based in Watertown, MA, providing life sciences organizations with access to healthcare stakeholder insight, tech-enabled analytics services, and extensive healthcare domain expertise.
Frazier is a leading private equity and venture capital firm in the pharmaceutical, healthcare services, and medical products industries based in Seattle, WA.
The Goodwin team was led by John Egan, Kristin Gerber, Brett Jackson, Luke Sutherland, and Isaiah Jeremy Marcano (Corporate); Bethany Withers and Nathan Wenk (IP/Licensing); Janet Andolina and Nicole Spitieri (Tax); Sarah Bock, Adrean Taylor and James Oh (Employee Benefits); April Sun, Jake Osborn, Justin Pierce and Gozde Guckaya (Global Trade); Kevin Grumberg and Anthony Shaheen (Debt); Carl Metzger and Cecilia Lockner (Insurance); Joseph Rocker (Litigation); Paul Jin and Brady Cummins (Antitrust); Roger Cohen and Nawa Lodin (Healthcare); James Yaworsky and Joseph Coughlin (Financial Analysis); and the invaluable support of Kimberly Larie.
For more details, read the press release.